XRX
34
-3
CSX
68
3
ETR
68
-3
ADI
45
-5
URBN
66
2
GILD
56
-4
EFX
41
-2
FTI
78
-3
QCOM
55
-2
FRT
48
2
PX
73
-6
SLG
62
-4
LB
63
-4
MLM
57
-3
SLB
56
-3
GIS
29
3
BA
45
-3
GLW
48
-5
CVX
38
6
AIG
47
6
XRX
34
-3
CSX
68
3
ETR
68
-3
ADI
45
-5
URBN
66
2
GILD
56
-4
EFX
41
-2
FTI
78
-3
QCOM
55
-2
FRT
48
2
PX
73
-6
SLG
62
-4
LB
63
-4
MLM
57
-3
SLB
56
-3
GIS
29
3
BA
45
-3
GLW
48
-5
CVX
38
6
AIG
47
6
Financhill
Back

Emergent BioSolutions Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
57

EBS
Emergent BioSolutions

Last Price:
9.27
Seasonality Move:
10.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Emergent BioSolutions Price Quote

$9.27
-0.70 (-7.02%)
(Updated: November 14, 2024 at 5:55 PM ET)

Emergent BioSolutions Key Stats

Buy
57
Emergent BioSolutions (EBS) is a Buy
Day range:
$9.26 - $10.02
52-week range:
$1.42 - $15.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.53
P/B ratio:
1.49%
Volume:
1.5M
Avg. volume:
1.4M
1-year change:
447.8%
Market cap:
$576.2M
Revenue:
$1B
EPS:
$-11.24

How Much Does Emergent BioSolutions Make?

Is Emergent BioSolutions Growing As A Company?

  • What Is Emergent BioSolutions's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.25%
  • What Is Emergent BioSolutions's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Emergent BioSolutions Stock Price Performance

What Is Emergent BioSolutions 52-Week High & Low?

Emergent BioSolutions Price To Free Cash Flow

Is It Risky To Buy Emergent BioSolutions?

Is Emergent BioSolutions Cash Flow Positive?

  • What Is EBS Cash Flow From Operations?
    Cash flow from operations (TTM) is $77M
  • What Is Emergent BioSolutions’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$48.5M
  • What Is Emergent BioSolutions’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45.7M

Emergent BioSolutions Return On Invested Capital

  • Is Management Doing A Good Job?
    EBS return on invested capital is -37.89%
  • What Is Emergent BioSolutions Return On Assets?
    ROA measures how assets are converting to revenues and is -31.86%
  • What Is EBS Return On Equity?
    ROE is a measure of profitability and is -87.53%

Emergent BioSolutions Earnings Date & Stock Price

Emergent BioSolutions Competitors

Emergent BioSolutions Dividend Yield

Emergent BioSolutions Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 874.53%
Revenue: -25.11% -1.24%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 20.36%

Major Shareholders

  • How many EBS shares are owned by institutional investors?
    42.8M EBS shares are owned by institutional investors
  • How many EBS shares are owned by insiders?
    3.9M EBS shares are owned by insiders